3D-Printed Organ Developer BioLife4D Registers for $50 M IPO

Published by , September 12, 2017 11:34 am

(MassDevice)  Chicago-based biological 3D printing developer BioLife4D has filed for a $50 million initial public offering as it looks to commercialize its cardiac tissue regeneration and organ replacement processes. The company said yesterday it is developing technologies with an end goal of creating a 3D bioprinted viable human heart suitable for transplant.
“Heart disease is the leading cause of death worldwide – killing one in four men and one in three women while outpacing all forms of cancer combined. BioLife4D is committed to transforming the treatment of heart disease, capitalizing on recent medical breakthroughs and optimizing a process that will ultimately give patients the gift of time,” BioLife4D CEO Steven Morris said in a press release.

Tags: , ,